Chemoinformaics analysis of 2-Methylheptadecane
Molecular Weight | 254.502 | nRot | 14 |
Heavy Atom Molecular Weight | 216.198 | nRig | 47 |
Exact Molecular Weight | 254.297 | nRing | 0 |
Solubility: LogS | -4.486 | nHRing | 0 |
Solubility: LogP | 4.105 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 55.3981 |
nHD | 0 | BPOL | 38.1219 |
QED | 0.246 |
Synth | 7.117 |
Natural Product Likeliness | 1.316 |
NR-PPAR-gamma | 0.081 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.994 |
Pgp-sub | 0.967 |
HIA | 0.843 |
CACO-2 | -5.424 |
MDCK | 0.0000172 |
BBB | 0.57 |
PPB | 0.894647 |
VDSS | 4.159 |
FU | 0.090595 |
CYP1A2-inh | 0.002 |
CYP1A2-sub | 0.976 |
CYP2c19-inh | 0.032 |
CYP2c19-sub | 0.932 |
CYP2c9-inh | 0.071 |
CYP2c9-sub | 0.174 |
CYP2d6-inh | 0.858 |
CYP2d6-sub | 0.882 |
CYP3a4-inh | 0.937 |
CYP3a4-sub | 0.936 |
CL | 6.41 |
T12 | 0.004 |
hERG | 0.961 |
Ames | 0.025 |
ROA | 0.997 |
SkinSen | 0.004 |
Carcinogencity | 0.175 |
EI | 0.005 |
Respiratory | 0.951 |
NR-Aromatase | 0.664 |
Antiviral | Yes |
Prediction | 0.635309 |